Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Reactogenicity & Immunogenicity of Tdap in Pregnancy

Vaccine; ePub 2018 Sep 13; Fortner, et al

Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine was well-tolerated in both pregnant and nonpregnant women, with pain at injection site more likely in pregnant women, a recent study found. Researchers compared local injection-site and systemic reactions and serologic response following Tdap in pregnant women (gestational age 20-34 weeks) and nonpregnant women and in pregnant women by self-reported prior Tdap receipt. Injection-site and systemic reactions were assessed for 1 week post-vaccination. They found:

  • 374 pregnant and 225 nonpregnant women were vaccinated.
  • Severe local or systemic reactions or “any” fever were uncommon in both groups.
  • Moderate/severe injection-site pain was significantly higher in pregnant vs nonpregnant women (18% vs 11%) but did not necessitate a healthcare visit.
  • Prior Tdap receipt did not increase occurrence of moderate/severe local or systemic reactions in pregnant women.
  • Serologic responses to all vaccine antigens were robust.

Citation:

Fortner KB, Swamy GK, Broder KR, et al. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. [Published online ahead of print September 13, 2018]. Vaccine. doi:10.1016/j.vaccine.2018.07.012.

Commentary:

This study highlights that the Tdap vaccine is very well tolerated. The side effect of local pain is a very well-expected phenomenon. The side effect was more common in pregnant women in this study, but this localized tenderness was mild and transient. The study showed that the vaccine had a good immune response which is important if we will give this vaccine every pregnancy to protect newborns from tetanus and pertussis. —John Russell, MD

This Week's Must Reads

HRRP & Patient Mortality in HF, AMI & Pneumonia, JAMA; 2018 Dec 25; Wadhera, et al

Hypertensive Diseases of Pregnancy & Risk of HF, Mayo Clin Proc; ePub 2018 Dec 19; Nizamuddin, et al

Clopidogrel + Aspirin Can Reduce Recurrent Stroke, BMJ; ePub 2018 Dec 18; Hao, Tampi, et al

Second-Line ADMs & CV Events in T2D, JAMA Netw Open; ePub 2018 Dec 21; O’Brien, et al

Health Care Utilization of a Dementia Care Program, JAMA Intern Med; ePub 2018 Dec 21; Jennings, et al

Must Reads in Vaccines

Acellular Pertussis Vaccine Is Safe & Effective, JAMA Pediatr; 2018 Nov; Wood, Nolan, et al

Influenza and Pertussis Vaccination in Pregnancy, Vaccine; ePub 2018 Nov 3; Wilcox, Bottrell, et al

Influenza Vaccine Efficacy in High-Risk Patients, Vaccine; ePub 2018 Nov 9; Shang, Chung, et al

Childhood Vaccination Coverage Rates Compared, J Paediatr Child Health; ePub 2018 Nov 13; Baumann, et al

Measles Immunity After Vaccination in Children with HIV, Clin Infect Dis; ePub 2018 Nov 12; Mutsaerts, et al